HighTower Advisors’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History
Bought
Maintained
Sold
Other funds holding ELAT
EC
WAM
HighTower Advisors's ELAT Position: Q4 2022 in Review
HighTower Advisors sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q4 2022, closing a stake of 9,558 shares — an estimated $200K sold.
HighTower Advisors first reported a position in ELAT in Q3 2021 and held it in 5 quarters. The position peaked at $640K in Q3 2021. 27 funds tracked by Wall St. Rank hold ELAT as of Q4 2022.
- HighTower Advisors reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q4 2022 after selling out during the quarter.
- HighTower Advisors sold 9,558 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q4 2022, an estimated $200K.
- HighTower Advisors first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q3 2021 and held it in 5 quarters.
- HighTower Advisors's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $640K in Q3 2021.
- 27 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q4 2022.
Based on HighTower Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.